The London Stock Exchange uses cookies to improve its website. The cookies for analytical purposes have already been set. For more details and how to manage cookies, please see our privacy and cookies policy.

Offer details
Expected size of offer (M): -
Expected first date of trading: 15/02/2002
Market: AIM
Location of address at which admission document will be available: -
Date at which admission document will be available: -

Advisors
Sponsor: -
Nominated Advisor (AIM Companies): Altium Capital Limited
Nominated Broker (AIM Companies): Gilbert Eliott & Co

Company details
Name Role
Jeremy Paul Scudamore Non-Executive Chairman
John Andrew Nicholson Chief Operating Officer
Dr David Edward Leahy Chief Scientific Officer
Robert William Long Non Executive Director
Dr Rosemary Ann Lucy Drake Non Executive Director
Dr Colin Picton Non Executive Director
Dr Mark Egerton Non Executive Director

Facts and Figures
Fiscal year end: - -
Incorporated in: England
Website URL: http://
space
Description of business:
Drug discovery and industrial scale testing for pharmaceutical companies.

Person(s) interested:
Paul Davidson 35.12 Martin Varley 7.58 Angus Monro 7.58 Robert Long 7.58 3i Group plc 5.25 Stephen Toon 3.82 The Charity Service 3.15


Cyprotex plc

Related links

Further informations about 7 and 7/30 days issues can be find by clicking on one of the options below:

Issues last 7 days

Last issues 7/30 days

Back to New and recent issues - Home



The Exchange accepts no responsibility for the content of the website you are now accessing or for any reliance placed by you or any person on the information contained on it.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds.

You are accessing the London Stock Exchange Annual Report Service powered by PrecisionIR.

The Exchange accepts no responsibility for the content of the reports you are now accessing or for any reliance placed by you or any person on the information contained therein.

By allowing this link the Exchange does not intend in any country, directly or indirectly, to solicit business or offer any securities to any person.

You will be redirected in five seconds